The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Minocycline: Therapeutic Potential in Psychiatry
Abstract
Pharmacological interventions to treat psychiatric illness have previously focused on modifying dysfunctional neurotransmitter systems to improve symptoms. However, imperfect understanding of the aetiology of these heterogeneous syndromes has been associated with poor treatment outcomes for many individuals. Growing evidence suggests that oxidative stress, inflammation, changes in glutamatergic pathways and neurotrophins play important roles in many psychiatric illnesses including mood disorders, schizophrenia and addiction. These novel insights into pathophysiology allow new treatment targets to be explored. Minocycline is an antibiotic that can modulate glutamate-induced excitotoxicity, and has antioxidant, anti-inflammatory and neuroprotective effects. Given that these mechanisms overlap with the newly understood pathophysiological pathways, minocycline has potential as an adjunctive treatment in psychiatry. To date there have been promising clinical indications that minocycline may be a useful treatment in psychiatry, albeit from small trials most of which were not placebo controlled. Case reports of individuals with schizophrenia, psychotic symptoms and bipolar depression have shown serendipitous benefits of minocycline treatment on psychiatric symptoms. Minocycline has been trialled in open-label or small randomized controlled trials in psychiatry. Results vary, with findings supporting use in schizophrenia, but showing less benefit for nicotine dependence and obsessive-compulsive disorder. Given the limited data from rigorous clinical trials, further research is required. However, taken together, the current evidence suggests minocycline may be a promising novel therapy in psychiatry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Minocycline promotes hippocampal neurogenesis and exerts anti-apoptotic and anti-inflammatory activities, reducing the expression of pro-inflammatory cytokines (e.g. IL-1β, IL-6, IL-2, TNF-α, INF-γ) and up-regulating anti-inflammatory cytokines (e.g. IL-10) [99].”
From Cognitive remission: a novel objective for the treatment of major depression? (2016) · cites this paper as [99]
Citations
Cites
1 retracted
Kernt, M. (2010) · Clinical ophthalmology · doi:10.2147/opth.s11216 · Cited by 34
RetractedA Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614
Inflammation is detrimental for neurogenesis in adult brain
Ekdahl, C. T., Claasen, J.-H., Bonde, S., Kokaia, Z., & Lindvall, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2234031100 · Cited by 1,559
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Self-citationOxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Self-citationZhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,069
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Research works printed but not linked: 2
- Garner, 2003, Cochrane Database Syst Rev, &NA;, CD002086
- Levine, 1996, Am J Psychiatry, 153, 582
Cited by
Sorted by citations
Items 101–131 of 131
Gholami, M., Ghelichkhani, Z., Aghakhani, R., Klionsky, D. J., Motaghinejad, O., Motaghinejad, M., Koohi, M. K., & Hassan, J. (2024) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_10_24 · Cited by 8
The Role of Antioxidants in the Management of Obsessive‐Compulsive Disorder
Baratzadeh, F., Elyasi, S., Mohammadpour, A. H., Salari, S., & Sahebkar, A. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6661514 · Cited by 8
Zebrafish as a potential model for stroke: A comparative study with standardized models
Borges, H. D. M., Dagostin, C. S., Córneo, E. D. S., Dondossola, E. R., Bernardo, H. T., Pickler, K. D. P., Pereira, B. D. C., de Oliveira, M. A., Scussel, R., Michels, M., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121200 · Cited by 7
Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
Bumb, J. M., Enning, F., & Leweke, F. M. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660165 · Cited by 7
Walker, A. J., Mohebbi, M., Maes, M. H. J., Berk, M., Walder, K. R., Bortolasci, C. C., Liu, Z. S.-J., Ng, C. H., Ashton, M. M., Berk, L., et al. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100581 · Cited by 6
Self-citationPotent Anti-Inflammatory Effects of Tetracyclines on Human Eosinophils
Gehring, M., Wieczorek, D., Kapp, A., & Wedi, B. (2021) · Frontiers in Allergy · doi:10.3389/falgy.2021.754501 · Cited by 5
Melink, Z., Lustberg, M. B., Schnell, P., Mezzanotte-Sharpe, J., & Orchard, T. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07457-w · Cited by 4
Anti-inflammatory Augmentation Therapy in Obsessive-compulsive Disorder: A Review
Ghasemi, H., Nomani, H., Sahebkar, A., & Mohammadpour, A. H. (2020) · Letters in Drug Design & Discovery · doi:10.2174/1570180817999200520122910 · Cited by 4
Bortolasci, C. C., Marx, W., Walker, A. J., Hasebe, K., Kavanagh, B. E., Morris, M. J., Mohebbi, M., Turner, A., Gray, L. J., Berk, L., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035080 · Cited by 3
Self-citationGünther, A., Chini, M., Bitzenhofer, S. H., Marquardt, A., & Hanganu‐Opatz, I. L. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106470 · Cited by 2
Buckley, P. F., & Foster, A. E. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_4 · Cited by 2
Bisogno, T., & Marzo, V. D. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch12 · Cited by 2
Microglia inhibition rescues developmental hypofrontality in a mouse model of mental illnessPreprint
Chini, M., Lindemann, C., Pöpplau, J. A., Xu, X., Ahlbeck, J., Bitzenhofer, S. H., Mulert, C., & Hanganu‐Opatz, I. L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/254656 · Cited by 2
FULGIONE, E., BABINO, G., D’AMBRA, I., GIORGIO, C. M., RONCHI, A., Guida, S., Marco, G. D., & ARGENZIANO, G. (2022) · Italian Journal of Dermatology and Venereology · doi:10.23736/s2784-8671.21.06943-7 · Cited by 1
Lounici, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1613152 · Cited by 1
Abbasi, A. A., Khan, H., Xu, S., Zhao, Y., Zhang, K., Shen, Y., Lv, J., Zhu, X., Fu, X., & Li, P. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.153248 · Cited by 1
Contemporary approaches to correction of cognitive impairment in endogenous depression
Oleichik, I. V., Shishkovskaia, T. I., & Баранов, П. А. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-4-82-93 · Cited by 1
Quantitative Evaluation of Microglial Activation and Vascularization in Suicide
Schnieder, T. P. (2014) · CUNY Academic Works (City University of New York)
Modulating Microglial Activation As a Possible Therapeutic Target for Depression
Sato‐Kasai, M., Kato, T. A., Ohgidani, M., Horikawa, H., Mizoguchi, Y., Monji, A., & Kanba, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-6580-4_18
Limandri, B. J. (2020) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20191218-03
Akhtar, Z. M., Hunt, E. R., Platt, B. N., Turner, A. L., Jacobs, C. A., Stone, A. V., & Duncan, S. T. (2021) · The Journal of Hip Surgery · doi:10.1055/s-0041-1739456
Obsessive Compulsive Disorder: Neurobiology and Treatment
Hoffman, K. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00161-4
Novos alvos terapêuticos para o transtorno afetivo bipolar
Carvalho, A. F. (2014) · Debates em Psiquiatria · doi:10.25118/2763-9037.2014.v4.247
The cocrystal 2-(dimethylammonio)-5-nitrobenzoate – 2-(dimethylamino)-5-nitrobenzoic acid, C9H10N2O4
Cui, J., Men, J., & Liu, B. (2022) · Zeitschrift für Kristallographie - New Crystal Structures · doi:10.1515/ncrs-2022-0101
Cytokines, Chemokines, and Inflammatory Indicators in Bipolar Disorder
Poletti, S., Dallaspezia, S., & Spadini, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_22-1
Cytokines, Chemokines, and Inflammatory Indicators in Bipolar Disorder
Poletti, S., Dallaspezia, S., & Spadini, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_22
Preclinical rodent studies support minocycline as an adjunctive anxiolytic
Skvarc, D., Lin, S. C., Croce, S., Bastawy, E. M., Smith, C. C., Drum, B., Panizzutti, B., & Dean, O. M. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111650
Self-citationGabriel-Segard, T. (2023) · theses.fr (ABES) · doi:10.70675/2f469c9fz7a22z4f47z9e37zcf0e1f890660
Tetracycline antibiotics: Emerging roles in neuropsychiatric disorders
Acar, A. Ş., Saday, Ö., & Erbaş, O. (2024) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2024.149
Golden window of intervention in PTSD: a synthesis of preclinical evidence
Kannan, D., Arun, M., Ravi, S., & Chakraborty, P. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07088-7
Vardanyan, R., & Vardanyan, G. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-51186-8.00006-3
Metadata
- Authors
- Dean, O. M., Data-Franco, J., Giorlando, F., & Berk, M.
- Affiliations
- Barwon Health (AU)
- Mental Health Research Institute (AU)
- The University of Melbourne (AU)
- Corresponding author
- Dean, Olivia M.
- Venue
- CNS Drugs
- Published
- 2012-05
- Volume
- 26
- Issue
- 5
- Pages
- 391-401
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W2159126784
- Cited by
- 131
- References
- 98
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 10 · 2023: 7 · 2022: 8 · 2021: 6 · 2020: 13 · 2019: 8 · 2018: 7 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 18 · 2013: 19 · 2012: 4
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yale University
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- minocycline, adjunctive therapy, schizophrenia, bipolar depression, psychosis, nicotine dependence, obsessive-compulsive disorder, oxidative stress, neuroinflammation, glutamate excitotoxicity, neuroprotection, antioxidant activity, mood disorders, addiction
- MeSH terms
- Animals, Anti-Bacterial Agents, Mental Disorders, Humans, Inflammation, Minocycline, Nerve Growth Factors, Drug Delivery Systems, Oxidative Stress, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
